Clinical Trial Update: Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating perioperative magnesium sulfate as a cerebral protector in neurosurgical patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Seizures

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Sara Varea | Conditions: Seizures (Incl Subtypes), Brain Tumor | Phase 3 | Status: COMPLETED